» Authors » Melanie Brooke Bernhardt

Melanie Brooke Bernhardt

Explore the profile of Melanie Brooke Bernhardt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 59
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Unguru Y, Bernhardt M, Berg S, Marie-Johnson L, Grimm K, Woodman C, et al.
Lancet Oncol . 2023 Feb; 24(2):e67. PMID: 36725147
No abstract available.
2.
Harris R, Bernhardt M, Zobeck M, Taylor O, Gramatges M, Schafer E, et al.
Cancer . 2023 Jan; 129(8):1287-1294. PMID: 36692972
Background: High-dose methotrexate (HD-MTX; 5000 mg/m ) is an important component of curative therapy in many treatment regimens for high-risk pediatric acute lymphoblastic leukemia (ALL). However, methotrexate therapy can result...
3.
Kirk S, Scheurer M, Bernhardt M, Mahoney D, Powers J
Am J Hematol . 2021 Mar; 96(6):E215-E218. PMID: 33735470
No abstract available.
4.
Brown A, Raghubar K, Taylor O, Bernhardt M, Kahalley L, Pan W, et al.
Support Care Cancer . 2020 Sep; 29(5):2455-2464. PMID: 32929538
Purpose: Despite improvements in frontline pediatric acute lymphoblastic leukemia (ALL) treatment, relapse remains a concern. Research in adult cancer patients suggests that patient-reported symptoms may predict survival, but the relationship...
5.
Wiernikowski J, Bernhardt M
Pediatr Blood Cancer . 2020 Feb; 67 Suppl 3:e28207. PMID: 32083372
The overall survival for children with cancer in high income countries is excellent. However, there are many disparities that may negatively affect survival, which are particularly problematic in low income...
6.
Rees C, Bernhardt M, Camp E, Lin J, Chumpitazi C
J Opioid Manag . 2019 Jul; 15(3):229-233. PMID: 31343724
Objective: To describe the prescription of hydrocodone-containing products (HCPs) and codeine-containing products (CCPs) by patient and provider race and ethnicity at two pediatric emergency departments (EDs) before and after the...
7.
Unguru Y, Bernhardt M, Berg S, Johnson L, Pyke-Grimm K, Woodman C, et al.
JAMA Pediatr . 2019 Mar; 173(5):477-484. PMID: 30830204
In resource-rich countries, 5-year survival rates for children with cancer approach 85%. This impressive statistic is largely the result of integrating research with clinical care. At the core of this...
8.
Cloyd C, Moffett B, Bernhardt M, Monico E, Patel N, Hanson D
Paediatr Anaesth . 2018 Sep; 28(11):982-986. PMID: 30207019
Background: Liposomal bupivacaine may be an option for reducing opioid utilization in pediatric scoliosis surgery. The use of liposomal bupivacaine in this patient population has not been previously described. Methods:...
9.
Chuk M, Widemann B, Minard C, Liu X, Kim A, Bernhardt M, et al.
Pediatr Blood Cancer . 2018 Apr; 65(8):e27077. PMID: 29693796
Background: We conducted a phase 1 trial to determine the maximum tolerated dose (MTD), toxicity profile, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity of cabozantinib in children with refractory or...
10.
Bernhardt M
Pediatr Blood Cancer . 2017 Jun; 64(10). PMID: 28561924
No abstract available.